← Leaderboards
Jessy D Dorn
Second Sight Medical Products, Inc.
$1,326,151
Attributed
$4,613,724
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2018–21$2M$1.5M$1M$500K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$4,613,724 · 1
By mechanism
UH3$4,613,724 · 1
Top collaborators
- Robert Jay Greenberg3 shared
- Nader Pouratian3 shared
- Daniel Yoshor2 shared
- Ashley L Feinsinger1 shared
Most similar at Second Sight Medical Products, Inc.
Same institution · by research overlap
- Robert Jay Greenberg$31,453,934
- Uday Kirit Patel$536,275
Others in their field
Other Emerging Leaders on “Prototype”
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$44,140,914
- Wally Narajowski$21,300,000
- Steven Schachter · Massachusetts General Hospital$19,630,330
- Maryellen Giger · University Of Chicago$14,002,824
- Neil King · University Of Washington$13,470,360
- Leah Johnson · Research Triangle Institute$10,876,154
Research focus
PrototypeVisionHuman SubjectProsthesisSuccessUnited StatesBaseGrantOptic NervePositioning AttributeSafetyBlindnessBrainThalamic StructureClinical ResearchClinical TrialsExperimental StudyDevicesImplantOcular ProsthesisBlindDesignPsychophysicsVisual Cortex
Grant awards (4)
Early Feasibility Clinical Trial of a Visual Cortical Prosthesis$1,400,752
UH3 · FY2021 · NS · contact PI
Early Feasibility Clinical Trial of a Visual Cortical Prosthesis$155,964
UH3 · FY2021 · NS · contact PI
Early Feasibility Clinical Trial of a Visual Cortical Prosthesis$1,452,263
UH3 · FY2020 · NS · contact PI
Early Feasibility Clinical Trial of a Visual Cortical Prosthesis$1,604,745
UH3 · FY2018 · NS · contact PI